March 5, 2014 4:32 pm
An Eyeforpharma report has some great information on adherence. There are many reasons given by patients for not adhering to their prescribed treatment. The most obvious are that they simply forgot to… more>>
The IMS Institute of Health Informatics released a report today called “riding the technology wave in life sciences” and there are some troubling findings. Among one of their key findings “despite abundant and growing amounts of data being generated and accessed by life sciences companies, analytic systems designed to interpret and create actionable insights have not kept pace.”
Once again the NY Times has taken the pharma industry to task with a front page story on the ADHD market. In fact the subtitle of the story “The Number of Diagnoses Soared Amid a 20-Year Drug Marketing Campaign”[pretty much sums up the article’s thesis. While it’s true that the drug industry has made some mistakes in marketing ADHD products let’s not forget that parents want an “easy fix” to get their kids better grades and patients still have to go through their physician to get an Rx.
Amanda Marcotte, via Slate said “Marshall was only given a few minutes to state that vaccines are safe and that the side effects mentioned by other guests were probably unrelated to the vaccine. Unfortunately, Couric and her producers allowed these facts to be totally overshadowed by the heartrending tales told by the two mothers. Despite H assurances that regular Pap smears are no big deal, the truth is that some women can’t or won’t go to the doctor as often as they should, especially in their 20s. Which is why the vaccine is so important: It’s easy, extra protection that will save some of their lives.” This is what happens when “journalists” lose their reporting skill and play to audience fears.
According to Business Intelligence “The TV business has had its worst year ever. Audience ratings have collapsed: Aside from a brief respite during the Olympics, there has been only negative ratings growth on broadcast and cable TV since September 2011, according to Citi Research.” While the national network news seems to be sponsored by pharma companies consumers are consuming media elsewhere and time shifting their favorite shows because repetitive tv commercials are downright annoying.
According to the NY Times “a decision announced Thursday by the Food and Drug Administration to suspend sales of a leukemia drug, Iclusig, that was keeping patients alive but also significantly raising their odds of heart attacks, strokes, blindness, death and amputations” has led to concern that patients who are using the drug to stay alive may soon find it hard to refill their prescriptions. “Despite the potential consequences, several doctors who treat people with the disease, chronic myeloid leukemia, said there were patients for whom nothing else works, and whose lives depend on the drug.” So who really should make the decision about treatment options ?
There is a lot, and I mean a lot, of health information on the Internet. Unfortunately there is also a lot of bad health information on the Internet and consumers have to pretty much figure out for themselves which sites offer credible and good health information, that they can understand, and which ones are full of garbage. What we should be worried about however is not all the health information that’s out there but what decisions consumers are making with information in hand.
According to today’s Times “The market for testosterone gels evolved because there is an appetite among men and because there is advertising,” said Dr. Joel Finkelstein, an associate professor at Harvard Medical School who is studying male hormone changes with aging. “The problem is that no one has proved that it works and we don’t know the risks.” Many experts say that pharmaceutical advertising promotes excessive and inappropriate drug use by convincing patients that they are ill — or have a more serious condition than is genuinely the case — and need medicine to treat it. While television viewers are barraged with advertising warning men they may have “low T,” Dr. Finkelstein said, “There is no such disease.”
There has been a lot of information bombarding DTC marketers lately, from e-books to studies on mobile health, but how are DTC marketers supposed to make sense of it all and what do you believe and use versus what is just nice to know. Realizing that time is short here are the key trends that every DTC marketer should understand to develop and execute a strategy that is patient focused and provides ROI.